20510 results for «»

Filter By

20510 results

Fatih Poyraz

Gaziantep, Türkiye

Rajendra Kumar Premchand

Secunderabad, India

Medically treated nonischemic thin-cap fibroatheroma lesions versus fractional flow reserve-guided complete revascularization in diabetic patients

27 Feb 2024

This sub-analysis denotes that medically treated diabetic patients with FFR-negative, TCFA-carrying target lesions were associated with a higher rate event rate compared to angiographically similar ischemic target lesions that underwent revascularization.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Medically treated nonischemic thin-cap fibroatheroma lesions vs FFR-guided complete revascularization in diabetic patients

The 2024 top Japanese abstracts

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding Japanese abstract submissions from PCR Tokyo Valves 2024, including a study on the effect of chronic kidney disease in clinical outcomes of Japanese patients treated with MitraClip system, and insight into the deformation of transcatheter heart valves with mitral valve-in-valve.

Why and when to use DCB?

06 Mar 2024

Watch the replay of this webinar to discuss why a PCI strategy without implantation of metallic stents may be a valid alternative and wich is the supporting evidence.

Why and when to use DCB?

Tailoring the TEER for an Asian patient

17 Feb 2024 – From PCR Tokyo Valves 2024

In this special session sponsored by Abbott, stay up to date with the latest real-world data from the EXPAND G4 study, understand the challenges that Asian heart anatomy presents for TEER therapy, and learn how the four clip sizes of the G4 MitraClip system can be...

Minimal-metal PCI: a drug-coated balloon philosophy combined with selective lesion stenting where necessary - the hybrid approach

13 Mar 2024

Watch the replay of this webinar with P. O'Kane, D. Pan and H. Routledge to understand what factors during PCI lead to the switch from DCB to DES and much more!

Minimal-metal PCI

The role of WATCHMAN therapy in optimising results and future perspectives

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.

Mastering techniques from basic to complex - Mitral regurgitation diagnosis and suitability for TEER

16 Feb 2024 – From PCR Tokyo Valves 2024

Learn to better diagnose mitral regurgitation and gain insight into the suitability of TEER for the situation through these slides. Explore the clinical scenarios and data that will help you choose.

Mitral and tricuspid intervention

17 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!

Rapid-fire - TAVI concomitant with CAD

17 Feb 2024 – From PCR Tokyo Valves 2024

In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!

Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve

17 Feb 2024 – From PCR Tokyo Valves 2024

This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.

Selection of the 2024 best clinical cases

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding clinical cases from PCR Tokyo Valves 2024, including a nightmare case with bicuspid aortic valve, pharmaco-invasive management of mechanical valve thrombus with cardiogenic shock, and a TAVR-in-TAVR challenge.

Rapid-fire - Tricuspid valve interventions in various situations

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!

Selection of the 2024 best abstracts

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...

Rapid-fire - Valve-in-Valve TAVI

17 Feb 2024 – From PCR Tokyo Valves 2024

Through these slides, gain valuable insights into valve-in-valve TAVI from a rapid-fire series of scenarios that cover structural valve deterioration after SAPIEN 3 implantation, a successful aortic valve-in-valve with balloon valve fracture and coronary protection, and TAV-in-SAV for an extremely small failed surgical valve.

Nightmare in mitral valve interventions: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

This selection of cases showcase nightmare scenarios during mitral valve interventions. Find out what difficulties might arise during MitraClip procedure, and learn how to prevent complications through optimal treatments and bailouts.

Nightmare in mitral valve interventions: sharing solutions together

PCR Webinars: Let's exchange on your needs!

27 Feb 2024

Being a digital member of the PCR family of courses, PCR Webinars takes advantage of the tradition and continuity and blends it with the novel opportunities of the digitalised world.

PCR Webinars: Let's exchange on your needs!

New devices for aortic intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.

New devices for aortic intervention

PCRonline @ ACC.24 Scientific Sessions

22 Mar 2024

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24

PCRonline @ ACC.24 Scientific Sessions
Didn’t find what you were looking for?